Home > Boards > Canadian > Internet - E-Commerce > Cyberads, Inc. (CYAD)

News: $CYAD Celyad Announces Third Quarter 2019 Financial

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
 
Followed By 115
Posts 15,042
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Celyad Oncology EPS beats by $0.29 Seeking Alpha - 8/4/2021 4:14:27 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/4/2021 4:03:37 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/21/2021 6:06:12 AM
Celyad Oncology highlights new CAR T product, gives data update Seeking Alpha - 7/20/2021 4:12:59 PM
Celyad Oncology presents early-stage data from blood cancer trial for CAR-T therapy Seeking Alpha - 6/11/2021 3:54:42 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/11/2021 8:00:57 AM
AMC, OCGN, SONO and HRTX among premarket gainers Seeking Alpha - 5/13/2021 8:23:40 AM
Celyad shares surge ahead of upcoming multiple myeloma study poster presentation Seeking Alpha - 5/13/2021 8:11:01 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/7/2021 4:18:43 PM
Celyad Oncology reports Q1 results Seeking Alpha - 5/6/2021 5:03:46 PM
New medical chief at Celyad Oncology Seeking Alpha - 4/19/2021 1:57:49 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 3/24/2021 5:19:00 PM
Celyad Oncology reports FY results Seeking Alpha - 3/24/2021 4:18:30 PM
Celyad Oncology reports FY results Seeking Alpha - 3/24/2021 4:17:14 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/2/2021 1:47:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/7/2021 7:29:15 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 12/7/2020 4:41:36 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/12/2020 10:24:17 AM
whytestocks   Tuesday, 11/19/19 07:00:24 AM
Re: None
Post # of 127 
News: $CYAD Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

MONT-SAINT-GUIBERT, Belgium, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced an update on its operational developments for the third quart...

Read the whole news CYAD - Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences